1. Home
  2. EYPT vs AMBC Comparison

EYPT vs AMBC Comparison

Compare EYPT & AMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • AMBC
  • Stock Information
  • Founded
  • EYPT 1987
  • AMBC 1971
  • Country
  • EYPT United States
  • AMBC United States
  • Employees
  • EYPT N/A
  • AMBC N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • AMBC Property-Casualty Insurers
  • Sector
  • EYPT Industrials
  • AMBC Finance
  • Exchange
  • EYPT Nasdaq
  • AMBC Nasdaq
  • Market Cap
  • EYPT 390.0M
  • AMBC 411.3M
  • IPO Year
  • EYPT 2005
  • AMBC 1991
  • Fundamental
  • Price
  • EYPT $5.81
  • AMBC $8.08
  • Analyst Decision
  • EYPT Strong Buy
  • AMBC Strong Buy
  • Analyst Count
  • EYPT 7
  • AMBC 2
  • Target Price
  • EYPT $24.00
  • AMBC $17.00
  • AVG Volume (30 Days)
  • EYPT 685.1K
  • AMBC 847.0K
  • Earning Date
  • EYPT 05-07-2025
  • AMBC 05-12-2025
  • Dividend Yield
  • EYPT N/A
  • AMBC N/A
  • EPS Growth
  • EYPT N/A
  • AMBC N/A
  • EPS
  • EYPT N/A
  • AMBC N/A
  • Revenue
  • EYPT $56,042,000.00
  • AMBC $240,754,000.00
  • Revenue This Year
  • EYPT N/A
  • AMBC N/A
  • Revenue Next Year
  • EYPT N/A
  • AMBC N/A
  • P/E Ratio
  • EYPT N/A
  • AMBC N/A
  • Revenue Growth
  • EYPT 12.04
  • AMBC 90.76
  • 52 Week Low
  • EYPT $3.91
  • AMBC $6.33
  • 52 Week High
  • EYPT $21.26
  • AMBC $18.45
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 48.48
  • AMBC 53.69
  • Support Level
  • EYPT $5.75
  • AMBC $7.92
  • Resistance Level
  • EYPT $7.45
  • AMBC $8.23
  • Average True Range (ATR)
  • EYPT 0.47
  • AMBC 0.24
  • MACD
  • EYPT -0.05
  • AMBC 0.11
  • Stochastic Oscillator
  • EYPT 22.35
  • AMBC 61.11

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About AMBC Ambac Financial Group Inc.

Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.

Share on Social Networks: